US FDA warns doctors to use cisapride as last resort only

被引：1

|

作者：

Ault, A

机构：

来源：

LANCET | 1998年 / 352卷 / 9122期

关键词：

D O I：

10.1016/S0140-6736(98)85030-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：120 / 120

页数：1

相关论文

共 50 条

[31] FDA warns against use of Artri and Ortiga products
[J]. Reactions Weekly, 2023, 1965 (1) : 4 - 4
[32] FDA warns against use of Soladek vitamin solution
[J]. Reactions Weekly, 2011, 1346 (1) : 4 - 4
[33] FDA warns against use of counterfeit Ozempic (semaglutide)
[J]. Reactions Weekly, 2024, 1990 (1) : 3 - 3
[34] Measuring the professionalization of US state courts of last resort
Squire, Peverill
[J]. STATE POLITICS & POLICY QUARTERLY, 2008, 8 (03) : 223 - 238
[35] US FDA warns of high estrogen levels with Ortho Evra Patch
[J]. Reactions Weekly, 2005, 1078 (1) : 2 - 2
[36] US FDA warns companies to stop distributing unapproved prescription narcotics
[J]. Reactions Weekly, 2009, 1247-1248 (1) : 3 - 3
[37] Use CCBs as last resort in treatment of hypertension
Wassertheil-Smoller, S
Psaty, B
Greenland, P
[J]. JOURNAL OF FAMILY PRACTICE, 2005, 54 (03): : 203 - 204
[38] FDA warns against use of Captomer for heavy metal toxicity
[J]. Reactions Weekly, 2014, 1507 (1) : 2 - 2
[39] FDA warns against use of OTC products to treat molluscum
[J]. Reactions Weekly, 2023, 1972 (1) : 3 - 3
[40] FDA warns against use of products containing aristolochic acid
[J]. Reactions Weekly, 2001, 849 (1) : 3 - 3

← 1 2 3 4 5 →